These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 1234999)
1. Experimental investigations with anti-cancer drugs for carcinogenicity with special reference to immunedepression. Schmähl D Recent Results Cancer Res; 1975; (52):18-28. PubMed ID: 1234999 [No Abstract] [Full Text] [Related]
2. Tumor inductions by cytostatics in man. Hunstein W Recent Results Cancer Res; 1975; (52):50-6. PubMed ID: 796914 [No Abstract] [Full Text] [Related]
3. Iatrogenic carcinogenesis. Schmähl D J Cancer Res Clin Oncol; 1981; 99(1-2):71-5. PubMed ID: 7251640 [TBL] [Abstract][Full Text] [Related]
4. Carcinogenic action of anticancer drugs with special reference to immunosuppression. Schmähl D Cancer; 1977 Oct; 40(4 Suppl):1927-9. PubMed ID: 332335 [TBL] [Abstract][Full Text] [Related]
5. Test for carcinogenicity of food additives and chemotherapeutic agents by the pulmonary tumor response in strain A mice. Stoner GD; Shimkin MB; Kniazeff AJ; Weisburger JH; Weisburger EK; Gori GB Cancer Res; 1973 Dec; 33(12):3069-85. PubMed ID: 4202501 [No Abstract] [Full Text] [Related]
6. The carcinogenic properties of some of the principal drugs used in clinical cancer chemotherapy. Weisburger JH; Griswold DP; Prejean JD; Casey AE; Wood HB; Weisburger EK Recent Results Cancer Res; 1975; (52):1-17. PubMed ID: 138176 [No Abstract] [Full Text] [Related]
7. Epidemiological studies of medically used drugs. Clemmesen J; Hjalgrim-Jensen S Arch Toxicol Suppl; 1980; 3():19-25. PubMed ID: 6930943 [TBL] [Abstract][Full Text] [Related]
8. Experimental investigations on immunodepressive properties of carcinogenic substances in male Sprague-Dawley rats. Scherf HR; Schmähl D Recent Results Cancer Res; 1975; (52):76-87. PubMed ID: 796916 [No Abstract] [Full Text] [Related]
10. THE TREATMENT OF CARCINOMA IN DOGS' BLADDERS WITH CYTOTOXIC DRUGS. BOYLAND E; KINDER CH; WILLIAMS K Invest Urol; 1965 Mar; 2():446-52. PubMed ID: 14261785 [No Abstract] [Full Text] [Related]
11. [The carcinogenic and anticarcinogenic properties of neozon D]. Pliss GB; Vlasov NN; Zabezhinskiĭ MA Vopr Onkol; 1991; 37(1):60-4. PubMed ID: 2014680 [TBL] [Abstract][Full Text] [Related]
13. Carcinogenicity of alkylating cytostatic drugs: conclusions and directions for future research. Kaldor J; Schmähl D IARC Sci Publ; 1986; (78):321-3. PubMed ID: 3583396 [No Abstract] [Full Text] [Related]
14. Carcinogenicity of alkylating agents. Weisburger EK Public Health Rep (1896); 1966 Sep; 81(9):772-6. PubMed ID: 4957936 [No Abstract] [Full Text] [Related]
15. Immune suppression and chemical carcinogenesis. Kroes R; Weiss JW; Weisburger JH Recent Results Cancer Res; 1975; (52):65-75. PubMed ID: 796915 [No Abstract] [Full Text] [Related]
16. [Carcinogenicity of anticancer agents]. Hayashi Y; Takahashi M; Yoshimura H Gan To Kagaku Ryoho; 1990 Dec; 17(12):2293-8. PubMed ID: 2260866 [TBL] [Abstract][Full Text] [Related]
17. New experimental approaches to reducing carcinogenicity in animals by modifying regimens. Habs M; Schmähl D IARC Sci Publ; 1986; (78):177-85. PubMed ID: 3108155 [No Abstract] [Full Text] [Related]